|
|
||||||||
1 From the Department of Pediatrics, 2 Central Microscopy Research Facility, and 3 Department of Ophthalmology, University of Iowa, Iowa City; 4 Alcon Research, Ltd., Fort Worth, Texas; and 5 The Howard Hughes Medical Institute, Iowa City, IA.
| Abstract |
|---|
|
|
|---|
METHODS. Normal human eyes and optic nerves from donors 62 to 83 years of age with no history of glaucoma were fixed, embedded in paraffin, and sectioned. Sections were hybridized with 35S-labeled sense and antisense riboprobes derived from a full-length MYOC cDNA.
RESULTS. High levels of MYOC expression were observed throughout the trabecular meshwork as well as in the most anterior nonfiltering meshwork (Schwalbes line), in the scleral spur, and in the endothelial lining of Schlemms canal. MYOC transcripts were also detected in the anterior corneal stroma, in the ciliary muscle, beneath the anterior border of the iris, in the iris stroma, and in the sclera. Expression in the retrolaminar region of the optic nerve was present in the pial septa that divide the nerve fiber bundles, in the perivascular connective tissue surrounding the central retinal vessels, and in the dura mater, arachnoid, and pia mater of the meningeal sheath surrounding the optic nerve.
CONCLUSIONS. MYOC gene expression in the trabecular meshwork, Schlemms canal, scleral spur, and ciliary muscle indicates a structural or functional role for myocilin in the regulation of aqueous humor outflow that may influence intraocular pressure. MYOC expression in the optic nerve suggests that changes in the structural, metabolic, or neurotropic support of the optic nerve may influence its susceptibility to glaucomatous damage.
| Introduction |
|---|
|
|
|---|
After the identification of the myocilin gene (MYOC) and its association with juvenile-onset open-angle glaucoma (JOAG) and typical late-onset POAG,2 3 4 much effort has been focused on understanding the normal role of myocilin in the eye, the effects of alterations in myocilin protein levels, and the contribution of dysfunctional forms of myocilin to the pathophysiology of POAG. Myocilin is a novel 57-kDa olfactomedin-related protein of yet undetermined function. Although the role of the olfactomedin-like domain in the pathophysiology of POAG is unknown, the evolutionary conservation of olfactomedin5 and the frequency of pathogenic mutations observed in the related myocilin domain6 7 and the influence of this domain on myocilin subunit interaction,8 9 possible phosphorylation,10 Triton solubility,11 and translational processing,12 imply that it plays an important role in the correct structure or function of the protein. Myocilin is found in multiple forms, both cellularly and extracellularly,8 9 13 14 15 16 17 18 19 as well as in cultured cells derived from human trabecular meshwork and Schlemms canal.8 13 15 16 18 It has been immunolocalized throughout the human eye,19 in the trabecular meshwork of normal and glaucomatous human eyes,13 14 and in the connecting cilium of mouse photoreceptor cells.20
One hypothesis is that altered myocilin expression or an altered form of the polypeptide may obstruct aqueous humor outflow through the trabecular meshwork and into Schlemms canal, leading to ocular hypertension.8 13 A recent report of myocilin immunolocalization in the optic nerve suggests that it also may be a target of glaucomatous damage in MYOC-linked POAG.19
The MYOC gene is widely expressed at the mRNA level, as assessed by Northern blot analysis and reverse transcriptionpolymerase chain reaction (RT-PCR) analysis of numerous adult human and mouse tissues.8 20 21 22 23 24 25 26 In contrast, the level of expression in developing mouse embryos, embryonic mouse eyes, and human fetal and newborn tissue is relatively low.21 25 27 Examination of dissected human ocular tissues or derived cell lines by Northern blot analysis and RT-PCR, as well as in situ hybridization analysis of mouse eyes and human trabecular meshwork, has demonstrated widespread MYOC expression in a number of structures, including the ciliary body, trabecular meshwork, iris, sclera, choroid, and retina.13 20 21 22 26 27 28 29
To date, there has been no comprehensive analysis of MYOC gene expression at the mRNA level in the intact human eye. To carefully evaluate expression in normal human eyes, we used in situ hybridization to localize MYOC transcripts in ocular tissues and expanded the study to include the optic nerve, which is the primary site of glaucomatous optic neuropathy. The widespread MYOC gene expression observed in this study suggests an important role for myocilin in the structure and function of the eye.
| Methods |
|---|
|
|
|---|
In Situ Hybridization
Serial 7-µm sections were mounted onto slides (Superfrost Plus;
Fisher Scientific, Fairlawn, NJ) and were hybridized with
35S-labeled sense and antisense MYOC
riboprobes generated from a full-length MYOC
cDNA23
that was subcloned into pBluescript II SK
(Stratagene, La Jolla, CA), linearized, and transcribed in
vitro using T3 and T7 RNA polymerases. Hybridization with labeled sense
RNA riboprobes served as controls for nonspecific hybridization, and in
all cases, no specific hybridization was observed. In situ
hybridization was performed as described previously.25
Briefly, tissue sections mounted on slides were hybridized overnight at
50°C in 50% formamide, 1x STE (0.3 M NaCl, 20 mM Tris [pH 8.0],
and 1 mM EDTA), 80 µg/ml denatured salmon sperm DNA, 1x Denhardts
solution, 10% dextran sulfate, 500 µg/ml yeast tRNA, and 0.1 M
dithiothreitol (DTT). After hybridization, slides were washed twice in
5x SSC-0.01 M DTT at 50°C for 30 minutes each, and once in 2x
SSC-50% formamide at 60°C for 30 minutes After treatment with RNAses
A and T1, slides were further washed in 2x SSC at 37°C, 0.1x SSC at
50°C, and 0.1x SSC at room temperature for 15 minutes each. After
dehydration, slides were dipped in photographic emulsion (NT2-B;
Eastman Kodak; Rochester, NY) and exposed for 1 to 2 weeks at 4°C.
Slides were developed and counterstained with hematoxylin and photographed with bright-field and dark-field microscopy. Images were collected digitally on a light microscope (Diaplan; Leitz, Rockleigh, NJ) with a cooled CCD camera (model DEI-750; Optronix, Goletta, GA). Images were converted to gray scale and sharpened, with brightness adjusted by computer (Photoshop; Adobe, San Jose, CA). The montages were laid out (IRIS Showcase; Silicon Graphics, Mountain View, CA) on a work station (Indy; Silicon Graphics).
Northern Blot Analysis
Freshly dissected postmortem human neurosensory retina and retinal
pigment epithelium (RPE)-choroid-sclera were frozen in liquid nitrogen
and stored at -70°C until use. Total cellular RNA was prepared using
RNA-STAT-60 (Tel-Test B, Friendswood, TX), and poly(A) mRNA was
isolated (MessageMaker mRNA Isolation System; Gibco, Gaithersburg, MD).
One microgram of poly(A) mRNA and RNA standards were electrophoresed
through a denaturing 0.8% agarose-formaldehyde gel, and the RNA was
transferred to a nylon membrane (Gene Screen Plus; NEN, Boston,
MA) using a standard method. The blot was hybridized with a
gel-purified insert of the MYOC cDNA plasmid described.
32P-dCTP DNA labeling, hybridization, and
autoradiography were performed as described previously.25
The blot was stripped of radioactivity and rehybridized with a cDNA
probe for ß-actin (Clontech, Palo Alto, CA) to assess equal loading
of RNA.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
After the identification of the MYOC gene and its association with POAG,4 much effort has been focused on understanding the role of myocilin in the pathophysiology of POAG. In this report, we used in situ hybridization to localize MYOC transcripts in normal human ocular tissues and optic nerve. Expression throughout the anterior segment was widespread. High levels of MYOC expression were seen throughout the trabecular meshwork, in agreement with previously published results using Northern blot analysis.21 27 Expression was also present in the scleral spur and in Schwalbes line, the nonfiltering region of the trabecular meshwork in the zone of transition between the corneal and trabecular endothelium. The elevated MYOC expression pattern seen in the trabecular meshwork is significant, because ocular hypertension is thought to result from increased aqueous humor outflow resistance through the trabecular meshwork, particularly the juxtacanalicular tissue and inner wall of Schlemms canal.34 Although the mechanism underlying outflow resistance in glaucoma is not yet clear, it is associated with ultrastructural and biochemical changes in the trabecular meshwork including deposition of extracellular material within the meshwork and beneath the endothelial lining of Schlemms canal.35
A role for myocilin in the structure or function of the trabecular meshwork was first suggested by its synthesis and secretion into the culture media of human meshwork cells after long-term treatment with dexamethasone.8 13 MYOC transcripts were subsequently localized in the trabecular meshwork of normal human eyes by in situ hybridization,29 and myocilin immunostaining in normal eyes has been reported throughout the trabecular meshwork and in the anterior nonfiltering region of the meshwork (Schwalbes line) and more abundantly in these regions of glaucomatous eyes.14 19 MYOC gene expression in both the trabecular meshwork and ciliary muscle supports a role for altered MYOC expression or an altered form of the polypeptide that may be dysregulated in the diseased state and contribute to ocular hypertension.8 13 It is noteworthy that not all patients with POAG who bear MYOC mutations have elevated intraocular pressure. A recent report of a relatively young patient with POAG with normal ocular tension, who had MYOC Gln368Stop mutation in exon 3,36 which is usually associated with moderately elevated intraocular pressure POAG,6 7 suggests a more complex disease pathogenesis that may involve other proteins that interact with myocilin and merits further investigation.
In addition to MYOC expression in the trabecular meshwork, transcripts were also detected in keratocytes of the anterior corneal stroma, beneath the anterior border of the iris, in the iris stroma, in scleral fibroblasts, and in the ciliary muscle. Expression was undetectable in the ciliary epithelium. This result differs somewhat from reports of Myoc expression in the mouse ciliary epithelium using in situ hybridization,28 myocilin immunolocalization in the ciliary epithelium and ciliary muscle of the human ciliary body,19 and RT-PCR analysis that demonstrated a high level of gene expression in cultured human ciliary muscle cells compared with a relatively low level of expression in a human nonpigmented ciliary epithelial cell line.26 One explanation for our results is that a low level of MYOC expression in the nonpigmented ciliary epithelium together with our use of higher stringency in situ hybridization conditions and posthybridization washes compared with those of Takahashi et al.28 may have resulted in absence of detectable expression.
In contrast to reports of Myoc expression in whole mouse retina, as assessed by Northern blot analysis24 ; in murine retinal photoreceptor cells and the ganglion cell layer, as assessed by in situ hybridization28 ; and in the human retinal nerve fiber layer and the inner and outer layers of photoreceptors, as assessed by myocilin immunostaining,19 we were unable to detect MYOC expression in the human retina. MYOC transcripts in human retina have also been reported to be undetectable by Northern blot analysis26 or to be present in low abundance after prolonged autoradiography.21 The integrity of the poly(A) mRNA used for our Northern blot analysis and the adjacent retinal tissue sections used for in situ hybridization analysis were verified independently and were shown to be reactive with a probe for NR2E3, a nuclear receptor gene associated with enhanced S cone syndrome, that is expressed in the neurosensory retina in greater abundance than MYOC.37 Although we cannot rule out the possibility of partial postmortem RNA degradation, our inability to detect MYOC transcripts in the neurosensory retina most likely resulted from a low level of gene expression coupled with the high-stringency hybridization conditions used in the in situ hybridization analysis.
We have provided new data in the present study that MYOC transcripts are localized in the retrolaminar region of the optic nervenotably, in the perivascular tissue surrounding the central retinal vessels, in the vascularized pial septa that divide and support the nerve fiber bundles, and in the dura mater, arachnoid, and pia mater of the meninges surrounding the optic nerve. These specialized connective tissues contribute structural support to the central retinal artery and vein, mechanical and nutritive support to the retinal ganglion axons as they traverse the optic nerve, and structural support to the optic nerve itself. We have also detected MYOC expression more anteriorly in glial cells of the optic nerve head using in situ hybridization and immunostaining of normal and glaucomatous eyes (unpublished results, 2000). According to recent reports, myocilin has been immunolocalized in human cultured optic nerve head astrocytes and lamina cribrosa cells derived from normal eyes,38 in cultured astrocytes derived from glaucomatous eyes,39 and in the optic nerve axons and lamina cribrosa astrocytes of the intact normal optic nerve head.19 Although we did not observe MYOC expression in optic nerve axons, one hypothesis suggests that myocilin is translated in the perikarya of optic nerve ganglions cells in the retina and transported to the optic nerve by axoplasmic flow.19
MYOC expression in the optic nerve head is significant, because this is the site of glaucomatous optic neuropathy, whether associated with a normal or elevated intraocular pressure. It is commonly believed that the site of damage to retinal ganglion axons is at the level of the lamina cribrosa.40 The lamina cribrosa, a fibroelastic connective tissue composed of a specialized extracellular matrix organized into a sievelike meshwork lined by astrocytes, provides mechanical and nutritive support to the axons as they leave the eye. During the progression of glaucoma, changes in the structural support of axons in the lamina cribrosa appear to reflect an aberrant remodeling of the lamina cribrosas extracellular matrix, leading to collapse of the cribriform plates and misalignment of its channels that may lead to axoplasmic flow obstruction.40 Studies indicate that the astrocytes may play a major role in the remodeling process.35 It is not yet clear whether this remodeling is the primary cause of glaucomatous injury or whether other insults, such as elevated intraocular pressure, ischemia, or axonal loss trigger the remodeling of the lamina cribrosa. MYOC expression in the optic nerve adds to a growing body of evidence suggesting that changes in the structural, metabolic, or neurotropic support of the optic nerve may influence its susceptibility to glaucomatous damage. Further analysis of the role of normal myocilin, altered myocilin levels, and dysfunctional myocilin in the structure or function of the optic nerve will provide new insight into the pathophysiology of both normal tension and hypertension in POAG.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication March 16, 2000; revised May 24, 2000; accepted May 31, 2000.
Commercial relationships policy: E (AC); all others N.
Corresponding author: Val C. Sheffield, The University of Iowa, Department of Pediatrics, 440 EMRB, Iowa City, IA 52242. val-sheffield{at}uiowa.edu
| References |
|---|
|
|
|---|
ß-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork Invest Ophthalmol Vis Sci 39,517-525This article has been cited by other articles:
![]() |
B. A. Pfeffer, C. A. DeWitt, M. Salvador-Silva, M. E. Cavet, F. J. Lopez, and K. W. Ward Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids Invest. Ophthalmol. Vis. Sci., January 1, 2010; 51(1): 437 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Kwon, H.-S. Lee, Y. Ji, J. S. Rubin, and S. I. Tomarev Myocilin Is a Modulator of Wnt Signaling Mol. Cell. Biol., April 15, 2009; 29(8): 2139 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, O. Grinchuk, and S. I. Tomarev Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1932 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Sodium 4-Phenylbutyrate Acts as a Chemical Chaperone on Misfolded Myocilin to Rescue Cells from Endoplasmic Reticulum Stress and Apoptosis Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1683 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Aggregated Myocilin Induces Russell Bodies and Causes Apoptosis: Implications for the Pathogenesis of Myocilin-Caused Primary Open-Angle Glaucoma Am. J. Pathol., January 1, 2007; 170(1): 100 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Gould, M. Reedy, L. A. Wilson, R. S. Smith, R. L. Johnson, and S. W. M. John Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma Mol. Cell. Biol., November 15, 2006; 26(22): 8427 - 8436. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Malyukova, H.-S. Lee, R. N. Fariss, and S. I. Tomarev Mutated Mouse and Human Myocilins Have Similar Properties and Do Not Block General Secretory Pathway Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Fautsch, C. K. Bahler, A. M. Vrabel, K. G. Howell, N. Loewen, W. L. Teo, E. M. Poeschla, and D. H. Johnson Perfusion of His-Tagged Eukaryotic Myocilin Increases Outflow Resistance in Human Anterior Segments in the Presence of Aqueous Humor Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 213 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Grinchuk, Z. Kozmik, X. Wu, and S. Tomarev The Optimedin Gene Is a Downstream Target of Pax6 J. Biol. Chem., October 21, 2005; 280(42): 35228 - 35237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Gould, L. Miceli-Libby, O. V. Savinova, M. Torrado, S. I. Tomarev, R. S. Smith, and S. W. M. John Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma Mol. Cell. Biol., October 15, 2004; 24(20): 9019 - 9025. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gobeil, M.-A. Rodrigue, S. Moisan, T. D. Nguyen, J. R. Polansky, J. Morissette, and V. Raymond Intracellular Sequestration of Hetero-oligomers Formed by Wild-Type and Glaucoma-Causing Myocilin Mutants Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3560 - 3567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ueda and B. Y. J. T. Yue Distribution of Myocilin and Extracellular Matrix Components in the Corneoscleral Meshwork of Human Eyes Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4772 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Tomarev, G. Wistow, V. Raymond, S. Dubois, and I. Malyukova Gene Expression Profile of the Human Trabecular Meshwork: NEIBank Sequence Tag Analysis Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2588 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goldwich, C. R. Ethier, D. W.-H. Chan, and E. R. Tamm Perfusion with the Olfactomedin Domain of Myocilin Does Not Affect Outflow Facility Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1953 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sohn, W. Hur, M. K. Joe, J.-H. Kim, Z.-W. Lee, K.-S. Ha, and C. Kee Expression of Wild-Type and Truncated Myocilins in Trabecular Meshwork Cells: Their Subcellular Localizations and Cytotoxicities Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3680 - 3685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Torrado, R. Trivedi, R. Zinovieva, I. Karavanova, and S. I. Tomarev Optimedin: a novel olfactomedin-related protein that interacts with myocilin Hum. Mol. Genet., May 16, 2002; 11(11): 1291 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Filla, X. Liu, T. D. Nguyen, J. R. Polansky, C. R. Brandt, P. L. Kaufman, and D. M. Peters In Vitro Localization of TIGR/MYOC in Trabecular Meshwork Extracellular Matrix and Binding to Fibronectin Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 151 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wentz-Hunter, J. Ueda, and B. Y. J. T. Yue Protein Interactions with Myocilin Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ahmed, M. Torrado, E. Johnson, J. Morrison, and S. I. Tomarev Changes in mRNA Levels of the Myoc/Tigr Gene in the Rat Eye after Experimental Elevation of Intraocular Pressure or Optic Nerve Transection Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3165 - 3172. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Clark, H. T. Steely, J. E. Dickerson Jr, S. English-Wright, K. Stropki, M. D. McCartney, N. Jacobson, A. R. Shepard, J. I. Clark, H. Matsushima, et al. Glucocorticoid Induction of the Glaucoma Gene MYOC in Human and Monkey Trabecular Meshwork Cells and Tissues Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1769 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jacobson, M. Andrews, A. R. Shepard, D. Nishimura, C. Searby, J. H. Fingert, G. Hageman, R. Mullins, B. L. Davidson, Y. H. Kwon, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor Hum. Mol. Genet., January 1, 2001; 10(2): 117 - 125. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |